Brief: Shilpa Medicare Says Subsidiary Received Certificate Of Suitability From EDQM For API, Teriflunomide
23/01/2025 08:38
Jan 23 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SUBSIDIARY RECEIVED CERTIFICATE OF SUITABILITY FROM EDQM
FOR
API, TERIFLUNOMIDE
Source text: ID:nBSE24mLds
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026